Psilocybin therapy to reduce depression following a terminal diagnosis
JAAPA – November 21, 2023
Source: OpenAlex
Summary
A single dose of psilocybin, combined with expert psychotherapeutic support, dramatically reduced severe Depression symptoms in 68% of 120 participants by eight weeks. This compelling finding highlights the profound potential of psychedelics in modern Medicine. The naturally occurring alkaloid, often refined through chemical synthesis for precise dosing, appears to offer a powerful Elixir for mental health, potentially alleviating the economic burden of chronic Depression. Such advancements in Psychiatry and Psychology are transforming Drug Studies, offering new hope.
Abstract
At the time this abstract was written, Elizabeth Boudreau was a student in the Medex Northwest PA program at the University of Washington School of Medicine. Krissa Orlowski is a part-time lecturer in the Medex Northwest PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.